期刊文献+

帕利哌酮缓释片治疗急性精神分裂症疗效及安全性的对照分析 被引量:1

下载PDF
导出
摘要 目的:探析帕利哌酮缓释片治疗急性精神分裂症疗效及安全性。方法:2016年1~12月,我院共收治96例急性精神分裂症患者,以随机数字表法进行分组,观察组48例,行帕利哌酮缓释片治疗;对照组48例,行利培酮治疗。对两组临床治疗效果以及治疗安全性进行对比。结果:由本次研究可知,在临床治疗有效率上,对照组远不及观察组,差异具有统计学意义(P<0.05)。在临床治疗安全性上,对照组同样远不及观察组,差异具有统计学意义(P<0.05)。结论:帕利哌酮缓释片在急性精神分裂症的临床治疗上具有极高的临床有效性及安全性,可在临床推广。
作者 李小新
出处 《北方药学》 2017年第10期156-157,共2页 Journal of North Pharmacy
  • 相关文献

参考文献6

二级参考文献71

  • 1沈渔邨.精神病学[M].5版.北京:人民卫生出版社.2009:838.
  • 2中华医学会精神科分会.中国精神障碍分类与诊断标准[M].3版.济南:山东科学技术出版社,2001:108-1150.
  • 3NASRALLAH H A. The case for long-acting antipsychotic agents in the post-CATIE era [ J ]. Acta Psychiatr Scand, 2007,115(4) :260-267.
  • 4LEYSEN J E, JANSSEN P M, MEGENS A A, et al. Ris- peridone: a novel antipsychotic with balanced serotonin- dopamine antagonism, receptor occupancy profile, and pharmacologic activity [ J ]. J Clin Psychiatry, 1994, 55 (Suppl) : 5-12.
  • 5PANDINA G, LANE R, GOPAL S, et al. A double-blind study of paliperidone palmitate and risperidone long-acting injectable in adults with schizophrenia [ J ]. Prog Nenropsychopharmacol Biol Psychiatry, 2011,35 ( 1 ) : 218- 226.
  • 6LI H, RU! Q, NING X,et al.A comparative study of pali- peridone palmitate and risperidone long-acting injectable therapy in schizophrenia [ J ] Prog Neuropsychopharmacol Biol Psychiatry, 2011,35 ( 4 ) : 1002-1008.
  • 7MOROSINI P L,MAGLIANO L, BRAMBILLA L, et al. Dev- elopment,reliability and acceptality of a new version of the DSM-IV social and Occupational Functioning Assessment Scale(SOFAS) to assess routine social functioning[ J] .Acta Psychiatr Scand, 2000,101 (4) : 323-329.
  • 8KARLSSON P, DENCKER E, NYBERG S, et al. Pharm- acokinetics and dopamine D2 and serotonin 5-HT2A receptor occupancy of paliperidone in healthy subjects: two open- label , single colse studies [ J ]. Clin Pharmacol Ther, 2005, 79 : 74.
  • 9NYBERG S, FARDE L, HALLDIN C, et al. D2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoate [ J ]. Am J Psychiatry, 1995,152 (2) : 173-178.
  • 10JUCKEL G, SCHAUB D, FUCHS N, et al.Validation of the Personal and Social Performance (PSP) Scale in a German sample of acutely ill patients with schizophrenia [ J ]. Schizophr Res,2008,104(1-3) :287-293.

共引文献67

同被引文献7

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部